Page Not Found
The first AI solution for PD-L1 supports cancer experts in the challenging assessment of PD-L1 stained lung tissue. It identifies tumorous cells and quantifies them to support scoring. Mindpeak Lung (NSCLC) PD-L1 (SP263) RoI for NSCLC helps to achieve accurate results without the need of manual fine-tuning.
Image analysis consists of the detection and classification of IHC stained tumor cells within predefined regions of interest (ROI). Tumor cells are classified as not-stained (tumor negative) or stained (tumor positive).
A corresponding tumor proportion score (TPS) is provided as the proportion of the number of positive tumor cells divided by the sum of tumor positive and tumor negative cells.
Step 1: Retrieve or select an image with the immunohistochemical PD-L1 staining suited for diagnosis and automated
Step 2: Select regions of interest suited for diagnosis and automated analysis.
Step 3: Mindpeak Lung (NSCLC) PD-L1 (SP263) RoI analyses the regions of interest and calculate the results
Step 4: Review, adjust and correct the results of the automated analysis in an integrated interactive viewer module.
Step 5: Conclude a final diagnostic decision.
Mindpeak Lung (NSCLC) PD-L1 (SP263) RoI is a stand-alone software module for automated image analysis. For interaction with the medical device it must be integrated into an interactive image viewer software that allows the user to manually select or correct regions of interest for analysis with the medical device.
Mindpeak Lung (NSCLC) PD-L1 (SP263) RoI runs as a web service either in the cloud or on a dedicated on-premise server in the laboratory network. The cloud variant is specified and provided by Mindpeak or distribution partners and requires no additional hardware by the user. For minimum requirements for an on-premise solution, please contact us.
The medical device supports the staining of the VENTANA PD-L1 (SP263) assay.
In conclusion of the identification, review, assessment, and analysis of the performance of the medical device, the medical device is considered to conform to the general safety and performance requirements according to the IVDD. For more information, please click here to see our study results.
Mindpeak Lung (NSCLC) PD-L1 (SP263) RoI detects and classifies cells into positively stained tumor and unstained tumor cells. One of its great advantages is its ability to differentiate between tumorous and non-tumorous structures, improving your scoring in the tumor microenvironment.
With Mindpeak Lung (NSCLC) PD-L1 (SP263) RoI you can manually choose the region of your interest on the whole slide
image allowing for automated PD-L1 quantification of specific tumor subpopulations.
The reliability of Mindpeak Lung (NSCLC) PD-L1 (SP263) RoI is unique: it provides accurate results even in challenging
contexts as it was developed with typical lab-specific variations in mind, such as slide preparation, staining and imaging
Mindpeak Lung (NSCLC) PD-L1 (SP263) RoI supports a broad range of scanners and can easily be integrated into existing workflows